Search Results
37 items found for "Aurelien Rizk"
Posts (11)
- Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental...
hypertension and proteinuria, with a worldwide incidence of 3–8% and high maternal mortality, is a risk Obesity, immunological diseases and endocrine metabolic diseases are high-risk factors for the development
- 📰 GPCR Weekly News, July 31 to August 6, 2023
intracellular agonist Conserved class B GPCR activation by a biased intracellular agonist The psychosis risk fibroblast heterogeneity in fibroblast-associated diseases Ultrasensitive dose-response for asbestos cancer risk Molecule Medicines Targeting G Protein-Coupled Receptors Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
Those include the risk of unintended off-target effects, limited selectivity due to closely related receptor A third advantage is that they offer the prospect of reducing the risk of overdose, given that their effects, allowing for the administration of substantial doses of allosteric modulators with a diminished risk
Other Pages (26)
- Ep 144 with Dr Aurélien Rizk
Aurélien Rizk About Dr. Aurélien Rizk "Dr. Integrating Mathematical Models and Biology: A Fascinating Discussion Yamina and Aurelien Rizk had a GPCRs, Software, and Fluid Dynamics Yamina Berchiche and Aurelien Rizk discussed the complexities of Aurelien Rizk also contributed to the conversation, highlighting the complexity of the process. Rizk discussed the differences between academia and the biotech industry, with Aurelien Rizk sharing
- Ep 18 with Dr. Yamina Berchiche
Oprea , Thomas Sakmar , Aurelien Rizk & Yaroslav Nikolaev .
- Ultrasensitive dose-response for asbestos cancer risk implied by new inflammation-mutation model
< GPCR News < GPCRs in Oncology and Immunology Ultrasensitive dose-response for asbestos cancer risk relationship is expected for damage that accumulates in proportion to dose, as hypothesized for increased risk concerning the nature of model-implied shape of the low-dose response for above-background increase in risk